Aston University has entered a partnership with Globe Biomedical to put smart eyewear through testing, with the glasses built to monitor myopia in the people wearing them. News-Medical reported the collaboration on Monday, 5 October 2026.
Under the arrangement described by News-Medical, the university's role is to carry out testing of the eyewear developed by Globe Biomedical. The device is intended to keep track of myopia, the vision condition commonly known as short-sightedness, in those who use it.
Myopia has become a growing concern in eye care as more people, particularly children and young adults, develop the condition. Continuous monitoring could give clinicians and researchers a clearer picture of how a person's vision changes over time rather than relying only on occasional clinic visits. News-Medical's report frames the Aston University–Globe Biomedical tie-up as a testing partnership, with the eyewear at the centre of the work.
Neither the specific testing methods nor a timeline for the trial was included in the material available. The report also did not state how many participants would be involved or where the testing would take place.
What to watch next: further details from Aston University or Globe Biomedical on how the eyewear testing will be run and what results emerge from it.
